Combination threapy of three kind of immune cells in the treatment of postoperative colorectal cancer, a prospective cohort study

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-PRCH-12002916

Enrollment

Unknown

Registered

2012-12-03

Start date

2006-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

immunotherapy:Standard surgery and postoperative chemotherapy combined immunotherapy

Control:Standard surgery and postoperative chemotherapy

Eligibility

Sex/Gender

All

Age

23 Years to 84 Years

Inclusion criteria

Inclusion criteria: colorectal cancer was diagnosed based on imaging studies and Pathology; TNM Stage of tumor was II, III and IV; Standard surgery and postoperative chemotherapy; No acute and severe complications including bleeding,obstruction; More than 18 years of age.

Exclusion criteria

Exclusion criteria: Refused to participation and without completely follow up information; Primary tumor without in the stomach; preoperative neoadjuvant or primary chemotherapy and radiotherapy; postoperative radiotherapy; Death within perioperative period; Autoimmune diseases; Severe allergic or adverse reaction.

Design outcomes

Primary

Measure	Time frame
survival;	—

Contacts

Public ContactXu Yingxin

xuyingx@126.com+86 010 66936935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026